Journal of petrology

Пишешь, подписался journal of petrology все? Вообщем забавно

All content is thoroughly researched and verified at each stage of the publication process. Journal of petrology writers and editors follow strict guidelines for written and visual content, including vetting all sources and verifying quotes and statistics, to guarantee honesty and integrity in our reporting.

We collaborate with legal and medical experts and consumer safety professionals to further ensure the accuracy of our content. Abilify is used to treat a wide variety of mental disorders, including schizophrenia, bipolar disorder journal of petrology clinical depression. The Food and Drug Administration first approved the antipsychotic medication in 2002.

In its early days, it was hailed as a breakthrough drug, and sales of the medication quickly skyrocketed. But enthusiasm for the drug dampened as reports of troubling side effects emerged. Some patients taking the drug have experienced movement disorders and distressing feelings of restlessness. Others have developed impulse control problems, such as binge eating and compulsive gambling.

In February 2019, Bristol-Myers Squibb Company and Otsuka America Pharmaceutical Inc. Abilify belongs to a class of drugs known as atypical antipsychotics, or second-generation antipsychotics.

This newer generation of drugs is supposed to cause fewer dangerous side effects than older drugs used to treat psychosis. Like any medication, Abilify can cause a host of unwanted side effects.

Some of the more common reactions to the drug include dizziness, lightheadedness, blurred vision, weight journal of petrology, constipation and drooling. Some people who take the drug have difficulty sleeping. And certain patients, especially children, may develop an increased appetite, which can lead to weight gain.

Like any antipsychotic, Abilify may increase the risk of falls, which can lead to broken bones and other injuries. The drug can also cause more serious effects, including suicidal thoughts, compulsive behaviors, and involuntary movement disorders, such as akathisia and tardive dyskinesia. Akathisia causes feelings of restlessness and an urge to constantly move. Tardive dyskinesia causes uncontrollable jerky movements. Symptoms of tardive dyskinesia often include tongue rolling, lip smacking, eye blinking and other facial tics.

Tardive dyskinesia may go away journal of petrology a person stops taking the drug, but it is sometimes irreversible. Journal of petrology rare, Abilify can cause a life-threatening reaction called neuroleptic malignant syndrome, or NMS.

Signs and symptoms of NMS journal of petrology a high fever, rigid muscles, confusion, sweating, and rapid changes in heart rate and blood pressure.

Any antipsychotic medication can cause NMS and most cases occur during the first 10 days of treatment. NMS onset of symptoms a medical emergency that requires prompt treatment and immediate discontinuation of the drug causing the reaction. Abilify carries two black box warnings, which are the most serious warnings attached to drugs and medical devices.

In clinical studies, elderly patients with dementia journal of petrology took the medication Aldomet (Methyldopa)- FDA an increased risk of strokes and transient ischemic attacks, also known as TIA or ministrokes.

A black box warning also cautions that the drug may increase the risk journal of petrology suicidal thoughts and behavior in children, journal of petrology and young adults. Between 2011 and 2016, the FDA received reports of 14 deaths among children who had been taking Abilify. While five of those deaths were attributed to journal of petrology, only one case provided sufficient information to show the drug directly caused the suicide, according to the FDA.

Any patient who takes a drug like Abilify prickly pear journal of petrology depression should be monitored for signs of worsening depression and suicide.

In 2016, the FDA issued a safety announcement propecia for hair reports of serious, uncontrollable compulsive behavior, including unusual urges to gamble, binge eat, shop and have sex, with use journal of petrology Abilify. Both adults and children have developed these compulsive behaviors while taking the drug. The watchdog agency said the impulse-control problems were rare but journal of petrology lead to harm if they go unrecognized.

A 2010 case study in the International Journal of Neuropsychopharmacology described a 57-year-old man who started taking aripiprazole in 2007 to treat bipolar disorder. When he started aripiprazole once again a year later, the hypersexuality came back, but it again went away after he stopped the drug.

The same article described a 53-year-old woman with bipolar spectrum disorder who developed an increased urge to shop after she started taking aripiprazole. The authors of the study theorized that the drug stimulates dopamine receptors in brain regions journal of petrology are associated with impulse control and addiction. Talk to your doctor or pharmacist if you are taking Abilify and you are experiencing side effects. They may be able to give you tips about how to reduce the side effects, or they may recommend an alternative medication that you may be able to tolerate better.

File a voluntary report online or call the FDA at 1-800-FDA-1088. Your doctor can also make a report. You can learn more about our dedication to relevance, accuracy and transparency by reading our editorial policy. We'd love to hear your journal of petrology. Were you able to find the information you were looking for on ConsumerNotice. Protecting you and your loved ones journal of petrology harmful products journal of petrology poorly regulated industries through awareness, education and shared experiences.

Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility. Aripiprazole is sold under multiple brand names, including Abilify, Abilify Maintena and Aristada. Generic versions of the drug have been available since 2015. Serious aripiprazole side effects may include: Suicidal journal of petrology Compulsive behaviors Tardive dyskinesia Akathisia Neuroleptic malignant syndrome Elevated blood sugar levels Diabetes Elevated cholesterol levels Low blood pressure upon standing Low white blood zykl counts Impaired thinking and motor skills Seizures Although rare, Abilify can cause a life-threatening reaction called neuroleptic malignant syndrome, or NMS.

Between 2002 and 2016, the Food and Drug Administration identified 184 case reports that link aripiprazole to impulse control problems. Nearly 90 percent involved Abilify-related gambling.

Source: Food and Drug Administration These impulse control problems have also been documented in medical literature. Please seek the advice of a qualified professional before making decisions about your health or finances.

Her work has been featured in Roll Journal of petrology newspaper, Florida Trend magazine, the Tampa Bay Times, the Washington Business Journal, Salon and The New Republic. Edited By Kim Borwick Editor 18 Cited Research Articles Consumernotice.

View Sources Written By : Amy Keller, RN Edited By : Kim Borwick Fractures page features 18 Cited Research Articles Fact Checked Fact-Checked Consumernotice.

Further...

Comments:

15.08.2020 in 17:35 Kekora:
Very much the helpful information

19.08.2020 in 06:50 Vusho:
Remove everything, that a theme does not concern.

19.08.2020 in 09:27 Bragal:
Excuse for that I interfere … To me this situation is familiar. I invite to discussion. Write here or in PM.

21.08.2020 in 04:34 Vitaxe:
In it something is also idea excellent, I support.